GIB Capital forecasts profit growth for Dr. Sulaiman Al Habib Medical Services stock
Published on 10/16/2026 at 10:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSForecast and valuation
- GIB Capital projected third-quarter net profit of SAR 720.44 million on October 11, 2026.
- Six-month net profit reached SAR 1,166 million on July 26, 2026.
- Market capitalization stood at SAR 77.9 billion on October 15, 2026.
Dr. Sulaiman Al Habib Medical Services (ISIN SA1510P1UMH1) is heading toward third-quarter results with a forecast net profit of SAR 720.44 million, up 19.62 percent from the year-earlier period, according to Argaam on October 11, 2026. The estimate places earnings expectations at the center of the stock story ahead of the reporting period.
Forecast points to stronger earnings
GIB Capital's forecast also puts third-quarter revenue at SAR 4,150.55 million, a 19.84 percent year-on-year increase. The figures cover the period ending September 30, 2026, and were published as part of the brokerage's Saudi earnings estimates, according to Argaam.
For investors, the comparison with the first half is important. The company reported six-month net profit of SAR 1,166 million for the period ended June 30, 2026, compared with SAR 1,148 million in the first half of 2025, according to Borsa Talk Gulf. That 1.57 percent increase provides a lower historical comparison than the current third-quarter forecast.
What does the forecast mean?
The forecast implies that the third quarter could contribute SAR 720.44 million to annual earnings, while the full-year 2026 estimate stands at SAR 2,682.20 million. Revenue for the year is projected at SAR 15,934.58 million, according to Arraf. These estimates make the published third-quarter result the next material test of the growth assumptions.
Three dates frame the results
On May 3, 2026, reported first-quarter net profit was SAR 503 million. On July 26, 2026, six-month net profit reached SAR 1,166 million. On October 11, 2026, GIB Capital forecast third-quarter net profit of SAR 720.44 million, according to Borsa Talk Gulf and Argaam.
The third-quarter reporting period ended September 30, 2026. The published forecasts give investors a defined benchmark for revenue and earnings when the company reports that period.
Stock valuation on October 15
The stock closed at SAR 222.60 on Tadawul on October 15, 2026, according to the structured market quote. Its 52-week range was SAR 210.10 to SAR 280.40, while market capitalization stood at SAR 77.9 billion on the same date. The close was 20.50 percent below the 52-week high, leaving the earnings release as a potential test of the valuation already reflected in the market.
Dr. Sulaiman Al Habib Medical Services at a glance
- Company: Dr. Sulaiman Al Habib Medical Services Group Company SJSC
- ISIN: SA1510P1UMH1
- Ticker: 4013.SR
- Primary exchange: Tadawul
- Last Tadawul price: SAR 222.60 on October 15, 2026
- Market capitalization: SAR 77.9 billion (as of October 15, 2026)
- 52-week range: SAR 210.10-280.40 (as of October 15, 2026)
- Sector / Industry: Health Care / Health Care Equipment and Services
Market context: Latest market reports.
More news and analyses on Dr. Sulaiman Al Habib Medical Services stock
